GHISELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 7.390
EU - Europa 3.704
AS - Asia 3.528
SA - Sud America 752
AF - Africa 226
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.617
Nazione #
US - Stati Uniti d'America 7.250
SG - Singapore 1.338
RU - Federazione Russa 634
UA - Ucraina 626
VN - Vietnam 625
BR - Brasile 576
CN - Cina 534
IT - Italia 477
DE - Germania 351
SE - Svezia 346
IE - Irlanda 331
TR - Turchia 282
HK - Hong Kong 265
FR - Francia 248
DK - Danimarca 234
FI - Finlandia 213
KR - Corea 126
GB - Regno Unito 118
CI - Costa d'Avorio 113
BD - Bangladesh 74
IN - India 66
AR - Argentina 58
CA - Canada 57
MX - Messico 56
IQ - Iraq 36
ZA - Sudafrica 34
MA - Marocco 33
CO - Colombia 30
JP - Giappone 29
EC - Ecuador 27
NL - Olanda 25
ID - Indonesia 22
PL - Polonia 21
PK - Pakistan 19
UZ - Uzbekistan 18
VE - Venezuela 18
BE - Belgio 16
ES - Italia 14
AT - Austria 13
MY - Malesia 13
CL - Cile 12
PH - Filippine 12
PY - Paraguay 12
OM - Oman 9
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
RO - Romania 8
SA - Arabia Saudita 8
EG - Egitto 7
JO - Giordania 7
UY - Uruguay 7
CR - Costa Rica 6
ET - Etiopia 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
DO - Repubblica Dominicana 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
EU - Europa 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
AZ - Azerbaigian 3
HR - Croazia 3
IR - Iran 3
LB - Libano 3
SN - Senegal 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GA - Gabon 2
KI - Kiribati 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CV - Capo Verde 1
DM - Dominica 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
Totale 15.602
Città #
Ashburn 1.221
Singapore 799
Jacksonville 623
Chandler 568
Fairfield 442
Dallas 392
San Jose 384
Dublin 331
Boardman 293
Hong Kong 255
Wilmington 246
Woodbridge 225
New York 217
Ho Chi Minh City 212
Seattle 189
Houston 172
Moscow 154
Hanoi 149
Ann Arbor 139
Beijing 137
Lawrence 131
Princeton 131
San Mateo 127
Cambridge 119
Lauterbourg 115
The Dalles 115
Abidjan 113
Los Angeles 95
Hefei 81
Des Moines 70
Munich 68
Buffalo 63
Turin 63
San Diego 52
Helsinki 50
São Paulo 50
Centro 49
Turku 44
Santa Clara 42
Orem 39
Da Nang 32
Milan 32
London 26
Mexico City 25
Chicago 23
Guangzhou 23
Denver 22
Council Bluffs 21
Haiphong 21
Johannesburg 21
Tokyo 21
Miano 20
Shanghai 20
Montreal 19
Chennai 18
Rome 18
Tashkent 18
Warsaw 18
Porto 17
Baghdad 16
Brasília 16
Atlanta 15
Brussels 15
Nuremberg 14
Ottawa 14
Rio de Janeiro 14
Izmir 13
Norwalk 13
Pune 13
Biên Hòa 12
Columbus 12
Manchester 12
Redmond 12
Belo Horizonte 11
Brooklyn 11
Buenos Aires 11
Guayaquil 11
Washington 11
Wuhan 11
Amsterdam 10
Ancona 10
Campinas 10
Falls Church 10
Fermo 10
Jakarta 10
Kilburn 10
Poplar 10
Ankara 9
Can Tho 9
Karachi 9
Phoenix 9
Salt Lake City 9
Stockholm 9
Curitiba 8
Dhaka 8
Dronten 8
Hải Dương 8
Mumbai 8
Boston 7
Caracas 7
Totale 9.625
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 333
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 265
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 208
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 200
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 195
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 192
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 182
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 181
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 172
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 171
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 168
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 165
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 161
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 157
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 156
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 152
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 148
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 147
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 146
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 146
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 142
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 142
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 141
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 140
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 138
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 138
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 138
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 138
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 137
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 136
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 136
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 134
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 131
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 131
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 127
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 127
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 125
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 124
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
The biocompatibility of dibutyryl chitin in the context of wound dressings. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 122
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 121
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 120
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 119
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 119
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 118
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 118
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 117
Urinary catheters and biofilm formation 117
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 117
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 116
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 115
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 115
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 114
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 113
LL-37 protects rats against lethal gram-negative sepsis. 111
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 111
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 110
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 110
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 110
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 110
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 110
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 108
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 106
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 105
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 105
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 104
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 102
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 101
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 100
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 99
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 99
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 99
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 99
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 98
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 97
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 97
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 97
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 96
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 96
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 95
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 94
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 94
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 94
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 93
Totale 13.197
Categoria #
all - tutte 70.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/20221.034 73 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/20252.426 283 190 131 123 104 159 249 113 455 118 247 254
2025/20265.742 371 479 435 587 569 406 992 584 555 436 124 204
Totale 15.770